ERBB2 and breast cancer: On first view, it seems that ER-negative, PR-negative and HER2-negative cells could more probably disseminate, corresponding to the worse prognosis of predominantly ERα-negative tumors and – inversely – to the demonstrated decreased invasiveness and metastatic potential of ERα-expressing breast cancer cells [56,57].